Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
January 09, 2017
Form 6-K
Source: SEC/Edgar
January 08, 2017
Form 6-K
Source: SEC/Edgar
January 05, 2017
Form 6-K
Source: SEC/Edgar
December 26, 2016
Form 6-K
Source: SEC/Edgar
December 18, 2016
Form 6-K
Source: SEC/Edgar
December 11, 2016
Form 6-K
Source: SEC/Edgar
December 04, 2016
Form 6-K
Source: SEC/Edgar
December 04, 2016
Form 6-K
Source: SEC/Edgar
November 29, 2016
Form 6-K
Source: SEC/Edgar
November 27, 2016
Form 6-K
Source: SEC/Edgar
November 21, 2016
Form 6-K
Source: SEC/Edgar
November 20, 2016
Form 6-K
Source: SEC/Edgar
November 14, 2016
Form 6-K
Source: SEC/Edgar
November 13, 2016
Form 6-K
Source: SEC/Edgar
November 13, 2016
Form 6-K
Source: SEC/Edgar
November 09, 2016
Form 6-K
Source: SEC/Edgar
November 06, 2016
Form 6-K
Source: SEC/Edgar
October 31, 2016
Form 6-K
Source: SEC/Edgar
October 31, 2016
Form 6-K
Source: SEC/Edgar
October 26, 2016
Form 6-K
Source: SEC/Edgar
October 25, 2016
Form 6-K
Source: SEC/Edgar
October 18, 2016
Form 6-K
Source: SEC/Edgar
October 10, 2016
Form 6-K
Source: SEC/Edgar
October 10, 2016
Form 6-K
Source: SEC/Edgar
October 02, 2016
Form 6-K
Source: SEC/Edgar
October 02, 2016
Form 6-K
Source: SEC/Edgar
September 28, 2016
Form 6-K
Source: SEC/Edgar
September 26, 2016
Form 6-K
Source: SEC/Edgar
September 22, 2016
Form 6-K
Source: SEC/Edgar
September 18, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.